We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
-9.45%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.13B
AUM Growth
-$263M
(-19%)
Cap. Flow
-$67.3M
Cap. Flow
% of AUM
-5.93%
Top 10 Holdings %
Top 10 Hldgs %
53.9%
Holding
81
New
2
Increased
39
Reduced
9
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AtriCure
ATRC
|
+$23.3M |
| 2 |
Bioventus
BVS
|
+$12.1M |
| 3 |
Prothena Corp
PRTA
|
+$7.77M |
| 4 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
+$7.75M |
| 5 |
SI-BONE Inc
SIBN
|
+$7.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$60M |
| 2 |
XENT
Intersect ENT, Inc
XENT
|
+$27.4M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$18.6M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$15.2M |
| 5 |
LITS
Lite Strategy Inc
LITS
|
+$13.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 84.11% |
| 2 | Communication Services | 6.42% |
| 3 | Energy | 0.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
AtriCure
ATRC
$1.92B
| $89.6M | 7.91% |
1,364,812
+359,823
| +36% | +$23.3M |
|
|
SPNE
2
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $85.2M | 7.51% |
7,005,788
+499,750
| +8% | +$6.08M |
|
|
MODN
3
DELISTED
MODEL N, INC.
MODN
| $72.8M | 6.42% |
2,707,143
+159,213
| +6% | +$4.15M |
|
|
4
Prothena Corp
PRTA
$425M
| $67.2M | 5.93% |
1,838,548
+215,607
| +13% | +$7.77M |
|
5
Halozyme
HALO
$9.79B
| $63.7M | 5.62% |
1,597,529
+85,686
| +6% | +$3.05M |
|
|
CUTR
6
DELISTED
Cutera, Inc.
CUTR
| $53.4M | 4.71% |
774,227
+117,354
| +18% | +$4.75M |
|
7
Tandem Diabetes Care
TNDM
$1.34B
| $50.6M | 4.47% |
435,305
+23,521
| +6% | +$2.75M |
|
8
Krystal Biotech
KRYS
$10.1B
| $47.8M | 4.21% |
717,936
+37,766
| +6% | +$2.36M |
|
9
Omnicell
OMCL
$1.61B
| $41.7M | 3.67% |
321,762
+16,867
| +6% | +$2.43M |
|
|
BCYC
10
Bicycle Therapeutics
BCYC
$269M
| $39.1M | 3.45% |
890,174
-110,609
| -11% | -$5.17M |
|
11
Keros Therapeutics
KROS
$199M
| $35.8M | 3.16% |
658,145
+106,047
| +19% | +$5.44M |
|
12
Ultragenyx Pharmaceutical
RARE
$2.45B
| $31.8M | 2.8% |
437,512
+26,199
| +6% | +$1.82M |
|
13
Alphatec Holdings
ATEC
$1.46B
| $31.3M | 2.76% |
2,718,120
+392,635
| +17% | +$4.25M |
|
14
CareDx
CDNA
$2.26B
| $26.7M | 2.36% |
722,073
+38,610
| +6% | +$1.5M |
|
|
15
SI-BONE Inc
SIBN
$788M
| $24.5M | 2.16% |
1,084,634
+364,391
| +51% | +$7.56M |
|
16
Health Catalyst
HCAT
$154M
| $22.4M | 1.98% |
858,733
+45,687
| +6% | +$1.3M |
|
|
XENT
17
DELISTED
Intersect ENT, Inc
XENT
| $19.6M | 1.73% |
699,235
-998,599
| -59% | -$27.4M |
|
18
Axogen
AXGN
$2.27B
| $19.2M | 1.7% |
2,423,335
+137,962
| +6% | +$1.19M |
|
|
FNA
19
DELISTED
Paragon 28, Inc.
FNA
| $18.7M | 1.65% |
1,118,603
+395,762
| +55% | +$6.37M |
|
|
AXNX
20
DELISTED
Axonics, Inc. Common Stock
AXNX
| $17.5M | 1.54% |
279,510
+143,758
| +106% | +$7.75M |
|
21
KORU Medical Systems
KRMD
$189M
| $17.4M | 1.54% |
6,099,820
+585,714
| +11% | +$1.75M |
|
22
Insmed
INSM
$21.4B
| $17.3M | 1.53% |
737,794
+39,425
| +6% | +$916K |
|
|
BLU
23
DELISTED
BELLUS Health Inc.
BLU
| $17.1M | 1.51% |
2,491,343
+164,815
| +7% | +$1.06M |
|
24
Codexis
CDXS
$151M
| $17.1M | 1.51% |
830,002
-259,148
| -24% | -$5.37M |
|
|
PHLT
25
DELISTED
Performant Healthcare Inc
PHLT
| $15.7M | 1.38% |
5,048,023
+161,850
| +3% | +$381K |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q1 2022 Portfolio in Review
As of Q1 2022, First Light Asset Management held 81 positions worth $1.13B, down 19% from $1.4B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
First Light Asset Management withdrew a net $67.3M in Q1 2022, closing 6 positions and reducing 9 holdings. Its most notable exit was Arena Pharmaceuticals Inc, an estimated $60M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 85% a quarter earlier, followed by Communication Services and Energy.
Against the trend, First Light Asset Management opened a new position in Bioventus worth $12.7M.
- First Light Asset Management's largest Q1 2022 buy was Bioventus: 901,525 shares worth $12.7M.
- First Light Asset Management added most to AtriCure in Q1 2022, an estimated $23.3M increase.
- First Light Asset Management's biggest Q1 2022 reduction was Intersect ENT, Inc, cutting an estimated $27.4M.
- First Light Asset Management fully exited Arena Pharmaceuticals Inc in Q1 2022, selling an estimated $60M.
- First Light Asset Management's ten largest holdings make up 54% of its $1.13B portfolio in Q1 2022.
- First Light Asset Management opened 2 new positions and closed 6 in Q1 2022.
- First Light Asset Management's portfolio value fell 19% quarter-over-quarter to $1.13B.
Based on First Light Asset Management's 13F filing for Q1 2022, filed 13 May 2022.